Related Experiment Videos
Treatment of hypertension in the elderly
1Divisions of Cardiology, Geriatrics, and Pulmonary/Critical Care, New York Medical College, Westchester Medical Center/New York Medical College, Valhalla, NY, USA.
Insights
Antihypertensive drug therapy significantly reduces cardiovascular events and mortality in elderly individuals. Treatment aims to lower blood pressure, but potential side effects like falls must be monitored.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Numerous double-blind, randomized, placebo-controlled studies confirm the benefits of antihypertensive drug therapy in reducing cardiovascular events in elderly populations.
- The Hypertension in the Very Elderly Trial (HYVET) provides key data on treatment efficacy in individuals aged 80 years and older.
Purpose of the Study:
- To summarize the evidence supporting antihypertensive drug therapy in elderly individuals.
- To outline treatment goals and potential adverse effects in this demographic.
Main Methods:
- Review of double-blind, randomized, placebo-controlled studies, including the Hypertension in the Very Elderly Trial.
- Analysis of cardiovascular event reduction and mortality data in treated elderly patients.
Main Results:
- Antihypertensive therapy led to a 30% reduction in stroke, 21% reduction in all-cause mortality, and 64% reduction in heart failure at 1.8-year follow-up in the HYVET study.
- Target blood pressure goals are <140/90 mmHg, or <130/80 mmHg for those with diabetes or chronic renal insufficiency.
Conclusions:
- Antihypertensive drug therapy is effective in reducing cardiovascular events and mortality in the elderly.
- Careful monitoring for adverse effects such as orthostatic hypotension, syncope, and falls is crucial in elderly patients receiving antihypertensive treatment.
Abstract:
Numerous double-blind, randomized, placebo-controlled studies have shown that antihypertensive drug therapy reduces cardiovascular events in elderly persons. In the Hypertension in the Very Elderly Trial, patients aged 80 years and older treated with antihypertensive drug therapy had, at 1.8-year follow-up, a 30 percent reduction in fatal or nonfatal stroke, a 39 percent reduction in fatal stroke, a 21 percent reduction in all-cause mortality, a 23 percent reduction in death from cardiovascular causes, and a 64 percent reduction in heart failure. The goal of treatment of hypertension in elderly persons is to lower the blood pressure to less than 140/90 mmHg and to less than 130/80 mmHg in older persons with diabetes or chronic renal insufficiency. All antihypertensive drugs may predispose the elderly person to develop symptomatic orthostatic hypotension and postprandial hypotension and syncope or falls. Adverse effects depend upon the antihypertensive drugs used, the doses of these drugs, the comorbidities in the elderly patients taking these drugs, and drug-drug interactions.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Drug Dosing: Geriatric Patients
Hypertension and Regulation of Blood Pressure
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Hypertension III: Clinical Manifestations and Diagnostic Studies